Hemodynamic abnormalities in acute myocardial infarction.
Great strides have been made in the management of patients with acute myocardial infarction since the advent of coronary care units. However, congestive heart failure continues to be the major cause of in-hospital mortality. The accurate diagnosis and classification of hemodynamic abnormalities allow the application of specific therapies for each patient. Because clinicians can now routinely measure left and right ventricular preload, systemic and pulmonary vascular resistance, cardiac output, and arteriovenous oxygen difference, pharmacologic and surgical interventions can be applied in a scientific manner. In addition, mechanical complications can be promptly recognized and aggressively treated. Although the mortality rate for patients with severe left ventricular dysfunction after myocardial infarction remains high, expert management offers an improved prognosis for many patients.
D002316:Cardiotonic Agents / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D005440:Fluid Therapy; D006339:Heart Rate; D006342:Heart Rupture, Post-Infarction / Q000209:etiology; D006439:Hemodynamics; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D008944:Mitral Valve Insufficiency / Q000209:etiology; D008991:Monitoring, Physiologic; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
D002316:Cardiotonic Agents; D004232:Diuretics; D014665:Vasodilator Agents